3D bioprinting could transform treatment for neurological disorders
Live Forever Club - 04-Aug-2025It’s still early days, but the technology could change medicine forever
Join the club for FREE to access the whole archive and other member benefits.
It’s still early days, but the technology could change medicine forever
Stalled protein production in ageing brains may trigger cognitive decline and inflammation
Dogs and cats linked to better memory and verbal skills in older adults, unlike fish or birds
This discovery suggests our brains stay flexible with age
Clearing sugar buildup might protect cells and slow decline
rTMS restores synaptic plasticity, offering hope for noninvasive Alzheimer’s interventions
Moderate physical activity made brains biologically younger
Non-invasive brain scans may soon help track focus, memory, and cognitive health over time
MIND diet may reduce dementia risk by 25%, especially with long-term improvements
Younger cohorts show lower dementia rates, but ageing and inequality keep total cases rising
Poor sleep linked to higher chances of Alzheimer’s and Parkinson’s, even without genetic risk
Researchers stress it shows association, not proof of cause
Only 10-20% of dementia patients qualify for costly treatment requiring genetic and MRI tests
New tool guides RNA to injury sites in neurons, offering hope for neurodegenerative therapies
Despite promising results, standardised protocols are still needed
AI-powered therapy offers new hope for ALS as early trials approach
PhotoPharmics secures $6 million to advance its home-based Celeste device
A UC San Diego study reveals how a common gene contributes to spontaneous Alzheimer’s disease
New research shows a 15% reduction in dementia diagnoses with targeted hypertension management
Pollution from factories and homes caused the most harm
New research links tech use in older adults to sharper thinking
Their compound PZL-A shows promise and a related drug has entered trials
It avoids common delivery problems and enters Phase 1 trials in 2025
New research reveals how Parkin, PINK1, and OMA1 act as guardians of cellular energy centres
Statins may help protect against dementia, regardless of cholesterol levels